Navigation Links
Genetic variation affects smoking cessation treatment
Date:9/20/2007

Philadelphia, PA, September 20, 2007 Mark Twain boasted that it was easy to quit smoking because he did it every day. We now may have the beginnings of understanding why some people find it so difficult to stop smoking even when they are in treatment for this problem. According to statistics provided by the Centers for Disease Control and Prevention (CDC), tobacco use is the leading preventable cause of death in the United States, and it is the second major cause of death in the world according to the World Health Organization (WHO). An estimated 20.9% of all US adults smoke, and even with a strong desire to quit, most find it exceptionally difficult. A new study being published in the September 15th issue of Biological Psychiatry reports that genetic variation in a particular enzyme affects the success rates of treatment with bupropion, an anti-smoking drug.

Lee and colleagues performed CYP2B6 genotyping on smoking individuals, a gene that is known to be highly variable and whose enzyme metabolizes both bupropion and nicotine. Participants were then provided with either placebo or bupropion treatment for ten weeks. The authors discovered that individuals with the CYP2B6*6 allele of the gene benefited from bupropion treatment and maintained abstinence longer while doing poorly on placebo, with a 32.5% abstinent rate vs. 14.3%, respectively. In contrast, those in the CYP2B6*1 group did well on both bupropion and placebo, with similar abstinence rates at the end of treatment and after a six month follow-up.

Rachel Tyndale, M.Sc., Ph.D., one of the authors on this study, comments, This first study, while requiring replication, identifies a very common genetic variant that appears to affect smoking cessation treatment outcome. This variant is present in 25-50% of people, thus affecting a large portion of the population.

John H. Krystal, M.D., Editor of Biological Psychiatry and affiliated with both Yale University School of Medi
'/>"/>

Contact: Jayne Dawkins
ja.dawkins@elsevier.com
215-239-3674
Elsevier
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Genetic Dentistry: Your Dentist may be able to grow you a new set of Teeth.
2. Crowning glory of 2000!!! Cracking of the genetic code is top of tops
3. Genetic influence in menopause
4. Genetic differences found between Male and Female brains
5. Genetic Breakthrough in Common Eye Problem
6. Inflammatory bowel disease linked to genetic abnormality
7. Genetic Code Of C.difficile Cracked
8. Genetics and cholesterol levels
9. Genetics helps in attacking cancer
10. DNA biochip for genetic screening
11. Genetic disorder related with sleep patterns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...mosomal change that raises odds for malignancy, st... News) -- Some Japanese survivors of the World War...xperienced key genetic changes that may have spark...arch indicates. , Papillary thyroid cancer (PTC...tion involving the so-called BRAF gene. But Japane...
(Date:8/29/2008)...RNewswire/ -- In response to recent news,about Mic...isease (CWD),members of the deer farming communit...ing season fast approaching, the tragic incident r...County farm understandably has,created concern amo...cross,the great state of Michigan. The deer farmin...
(Date:8/29/2008)... to More Than 30 European Countries, HONOLULU, Au...d today,that it has successfully completed the int...ical Device Directive (for most European Union cou...rk -- or Conformite Europeene Mark,-- for the Life...na,s,patient safety reach to include more than 30 ...
(Date:8/29/2008)...presents Telemedicine Encounter Management Systems...ions as a possible solution to national health car...d, MA (PRWEB) August 29, 2008 -- If there has been...s at the Democratic National Convention it has bee...ional health care issues., , ,Our Democratic leade...
Breaking Medicine News(10 mins):Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 3Health News:Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 3Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 4Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2
...ability to speak, communicate and relate to others...ence Autism Speaks, a non-profit organization has ... be created on autism. // It was founded in 2005.... between the patients, doctors, researchers and th...
... M.D., and colleagues say that mutation in CCR5 (c...nfection but increases the risk of developing West...NV) illness is caused due to a mosquito-borne viru...tional Institute of Allergy and Infectious Disease...
...ool in Scotland with the object of preventing chil.... Seminars are proposed to be conducted in schools...e reportedly resulting in the number of skin cance... Thomas Muir High School are reported to be going ...
...colleagues of the University of Texas Health Scien...he rat acts as an anti-depressant. Leptin is a hor...ulation. // The research was done on chronic unpre... that CUS rats had decreased levels of Leptin than...
Other Medicine News:Health News:CCR5 Mutation Confers Immunity Against HIV But Not Against West Nile Virus Illness 2Health News:Leptin, The Next Generation Antidepressant? 2
(Date:8/25/2008)...Y HILLS, Mass., Aug. 25 /- Joseph F. ... of Spherics, Inc. ("Spherics") for,the benefit of...l,intellectual property will be sold at a sealed b...tended release formulation of Levodopa-Carbidopa t...kinson,s disease, with global,sales estimated at a...
(Date:8/25/2008)...O, Calif., Aug. 25 /- Anthera Pharmac...company developing,anti-inflammatory drugs, today ...urrent Acute coronary events with Near-term Cardio...designed to examine the impact of,varespladib when...ute,Coronary Syndrome (ACS) event., The FRANCIS t...
(Date:8/22/2008)...men Enrolled in Trial Sponsored by Medical Researc...FirstCall/ -- Indevus,Pharmaceuticals, Inc. (Nasda...lment in Protocol MDP 301, a Phase III clinical tr...icrobicide for the prevention of HIV and other,sex...ed by the United,Kingdom,s Medical Research Counci...
(Date:8/22/2008)...E, Md., Aug. 22 /- Human Ge...ed that it has completed the,enrollment and initia... of,HGS-ETR1 (mapatumumab) in combination with the... first-line therapy in advanced non-small cell,lun.../cgi-bin/prnh/20080416/HGSLOGO ), "There is an u...
Breaking Medicine Technology:Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5RIVAs Cutting Edge Technology To Help Intermountain Healthcare Enhance Medication Delivery Safety 14295 1RIVAs Cutting Edge Technology To Help Intermountain Healthcare Enhance Medication Delivery Safety 14295 2HRSA Launches Digital Campaign to Promote Poison Awareness and Prevention 14292 1HRSA Launches Digital Campaign to Promote Poison Awareness and Prevention 14292 22007 Procedural Survey Reveals a Two Year Increase in Age of Patients Seeking Cosmetic Surgery 14289 12007 Procedural Survey Reveals a Two Year Increase in Age of Patients Seeking Cosmetic Surgery 14289 2Rodent study finds artificial butter chemical harmful to lungs 14287 1Rodent study finds artificial butter chemical harmful to lungs 14287 2
...Maintained Improvement in Personal and Social,Pe...07 /PRNewswire/ --,Longer-term treatment with IN..., a new once daily oral medication for,schizophr...ir,symptoms and maintain their improvements in p... data are from a large, open label, international,...
...nforce Astellas Commitment to Overcoming Critical,...many, April 02, 2007 /PRNewswire/ --Study results,...l Microbiology,and Infectious Diseases (ECCMID) sh...gal micafungin, both have the potential,to meet a ...s,hospital-acquired infections (HAIs). , Hospital-...
Other Medicine Technology:Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 2Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 3Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 4Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 5Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 6Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 2Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 3Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 4Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 5
The Smith & Nephew ECTRA II systems permit the surgeon to access and release the carpal tunnel ligament endoscopically, allowing access via two portals for distal and proximal cutting, while minimizi
... System provides a unique option for the correctio...arly the opening wedge osteotomy of the first meta...mall Fragment Plate and Screw Set is a complete tr...es the plates, screws, and drills. It provides a m...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d
Medicine Products: